$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

$cpsh Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924007808 Filed on March 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$5.913M	$6.747M	$27.55M
YoY Change		-0.01%	3.62%
Cost Of Revenue	$5.006M	$5.599M	$20.73M
YoY Change		15.08%	7.46%
Gross Profit	$906.3K	$1.149M	$6.825M
YoY Change		-39.01%	-6.52%
Gross Profit Margin	15.33%	17.02%	24.77%
Selling, General & Admin	$1.166M	$1.005M	$5.126M
YoY Change		-14.44%	1.17%
% of Gross Profit	128.64%	87.49%	75.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$101.4K	$125.8K	$489.1K
YoY Change		19.99%	9.73%
% of Gross Profit	11.19%	10.95%	7.17%
Operating Expenses	$1.166M	$1.005M	$5.126M
YoY Change		-14.44%	1.17%
Operating Profit	-$259.6K	$143.6K	$1.699M
YoY Change		-79.73%	-23.95%
Interest Expense	-$830.00	$49.43K	$225.8K
YoY Change		-2715.34%
% of Operating Profit		34.41%	13.28%
Other Income/Expense, Net	$79.17K	$31.39K	$27.26K
YoY Change		-95.14%	-95.83%
Pretax Income	-$180.4K	$224.5K	$1.952M
YoY Change		-83.4%	-32.39%
Income Tax	-$37.29K	$84.95K	$582.1K
% Of Pretax Income		37.85%	29.81%
Net Earnings	-$143.2K	$139.5K	$1.370M
YoY Change		-85.88%	-35.71%
Net Earnings / Revenue	-2.42%	2.07%	4.97%
Basic Earnings Per Share	-$0.01		$0.09
Diluted Earnings Per Share	-$0.01	$0.01	$0.09
COMMON SHARES
Basic Shares Outstanding	14.52M	14.52M	14.50M
Diluted Shares Outstanding	14.52M		14.63M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.668M	$8.814M	$8.814M
YoY Change		57.43%	6.62%
Cash & Equivalents	$8.668M	$8.814M	$8.814M
Short-Term Investments
Other Short-Term Assets	$392.0K	$276.4K	$276.4K
YoY Change		12.03%	30.82%
Inventory	$4.611M	$4.582M	$4.582M
Prepaid Expenses
Receivables	$3.849M	$4.389M	$4.472M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.55M	$18.14M	$18.14M
YoY Change		9.64%	1.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.718M	$1.556M	$1.888M
YoY Change		10.46%	5.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.610M	$1.570M	$1.570M
YoY Change		-25.89%	-24.15%
Total Long-Term Assets	$3.625M	$3.458M	$3.458M
YoY Change		-14.07%	-10.47%
TOTAL ASSETS
Total Short-Term Assets	$17.55M	$18.14M	$18.14M
Total Long-Term Assets	$3.625M	$3.458M	$3.458M
Total Assets	$21.17M	$21.60M	$21.60M
YoY Change		5.0%	-0.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.410M	$2.535M	$2.535M
YoY Change		23.97%	38.01%
Accrued Expenses	$843.8K	$1.075M	$1.235M
YoY Change		24.22%	26.31%
Deferred Revenue	$207.2K	$251.8K
YoY Change		-85.25%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$43.48K	$46.80K	$46.80K
YoY Change		8.48%	7.07%
Total Short-Term Liabilities	$3.664M	$4.069M	$4.069M
YoY Change		-15.54%	-24.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$8.090K	$8.090K
YoY Change		-87.73%	-85.25%
Other Long-Term Liabilities	$168.3K	$203.3K	$203.3K
YoY Change		-40.21%	-62.36%
Total Long-Term Liabilities	$168.3K	$211.4K	$211.4K
YoY Change		-47.93%	-64.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.664M	$4.069M	$4.069M
Total Long-Term Liabilities	$168.3K	$211.4K	$211.4K
Total Liabilities	$3.833M	$4.280M	$4.280M
YoY Change		-18.06%	-28.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.90M	-$22.75M
YoY Change		-6.72%
Common Stock	$146.0K	$146.0K
YoY Change		1.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$250.1K	$250.1K
YoY Change		1099.76%
Treasury Stock Shares
Shareholders Equity	$17.34M	$17.32M	$17.32M
YoY Change
Total Liabilities & Shareholders Equity	$21.17M	$21.60M	$21.60M
YoY Change		5.0%	-0.36%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$143.2K	$139.5K	$1.370M
YoY Change		-85.88%	-35.71%
Depreciation, Depletion And Amortization	$101.4K	$125.8K	$489.1K
YoY Change		19.99%	9.73%
Cash From Operating Activities	$128.9K	$196.9K	$1.267M
YoY Change		-70.23%	-64.31%
INVESTING ACTIVITIES
Capital Expenditures	$263.3K	$150.9K	$718.3K
YoY Change		-249.93%	63.33%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$263.3K	-$150.9K	-$718.3K
YoY Change		49.93%	64.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$11.41K	-11.23K	-$2.306K
YoY Change		-70.83%	-102.27%
NET CHANGE
Cash From Operating Activities	$128.9K	196.9K	$1.267M
Cash From Investing Activities	-$263.3K	-150.9K	-$718.3K
Cash From Financing Activities	-$11.41K	-11.23K	-$2.306K
Net Change In Cash	-$145.9K	34.77K	$546.9K
YoY Change		-93.34%	-83.0%
FREE CASH FLOW
Cash From Operating Activities	$128.9K	$196.9K	$1.267M
Capital Expenditures	$263.3K	$150.9K	$718.3K
Free Cash Flow	-$134.5K	$46.00K	$549.2K
YoY Change		-93.96%	-82.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14601487
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14460486
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14519215
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14450470
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	82272
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	10016
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	254281	usd
CY2023Q4	cpsh	Unrecognized Tax Benefits Uncertain Tax Positions UnrecognizedTaxBenefitsUncertainTaxPositions	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.11
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-16088
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2832509
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	111 South Worcester Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Norton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02766-2102
CY2023	dei	City Area Code CityAreaCode	508
CY2023	dei	Local Phone Number LocalPhoneNumber	222-0614
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	CPSH
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	34000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14519215
CY2023	dei	Auditor Firm AuditorFirmId	392
CY2023	dei	Auditor Name AuditorName	Wolf & Company, P.C.
CY2023	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8813626	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8266753	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4389155	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3777975	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	83191	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	685668	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4581930	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4875901	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	276349	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	211242	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18144251	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	17817539	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11271982	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10770427	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	952883	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	952883	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	985649	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	985649	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13210514	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12708959	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11936004	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11446901	usd
CY2023Q4	cpsh	Construction In Progress Net ConstructionInProgressNet	281629	usd
CY2022Q4	cpsh	Construction In Progress Net ConstructionInProgressNet	64910	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1556139	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1326968	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	332000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	466000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1569726	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2069436	usd
CY2023Q4	us-gaap	Assets Assets	21602116	usd
CY2022Q4	us-gaap	Assets Assets	21679943	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	46797	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	43711	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2535086	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1836865	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1075137	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	820856	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	251755	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2521128	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4068775	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5379560	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	8090	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	54847	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31277	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	231020	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	172000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	309000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4280142	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5974427	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	146015	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	144605	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40180893	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39726851	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22754796	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24125092	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	250138	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	40848	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17321974	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15705516	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21602116	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21679943	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27550646	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26586926	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20725237	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19285846	usd
CY2023	us-gaap	Gross Profit GrossProfit	6825409	usd
CY2022	us-gaap	Gross Profit GrossProfit	7301080	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5126046	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5066660	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1699363	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2234420	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	225757	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12015	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27261	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	641233	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1952381	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2887668	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	582085	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	756268	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1370296	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2131400	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14495709
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14424381
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14628811
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14675646
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13166311	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	250359	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	157446	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2131400	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15705516	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	204797	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41365	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1370296	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17321974	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1370296	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2131400	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	204797	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	250359	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	489103	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	445739	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-499710	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-754542	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3400	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	611180	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1092046	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-602477	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	685668	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-293971	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	964299	usd
CY2023	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	65107	usd
CY2022	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-14631	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	698221	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-263386	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-265575	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2469116	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1045010	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1267453	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3551399	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	718274	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	439772	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3400	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-718274	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-436372	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	41365	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	157446	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	43671	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	56032	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2306	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	101414	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	546873	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3216441	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8266753	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5050312	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8813626	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8266753	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	111456	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	456	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5096	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	7954	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	209290	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	38333	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	10000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	cpsh	Contract With Customer Rebates ContractWithCustomerRebates	0	usd
CY2023Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">(</span><i><span style="text-decoration: underline; "><em style="font: inherit;">2</em></span></i><span style="text-decoration: underline; ">)(i) Reclassification</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain amounts in prior year’s financial statements have been reclassified to conform to the current year’s presentation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">(</span><i><span style="text-decoration: underline; "><em style="font: inherit;">2</em></span></i><span style="text-decoration: underline; ">)(k) Use of Estimates in the Preparation of Financial Statements</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the amounts of revenues and expenses recorded during the reporting period. Such estimates are adjusted by management periodically as a result of existing or anticipated economic changes which effect, or <i><em style="font: inherit;"> may </em></i>effect, the Company’s financial statements. Actual results could differ from these estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2023	us-gaap	Fiscal Period FiscalPeriod	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">(</span><i><span style="text-decoration: underline; "><em style="font: inherit;">2</em></span></i><span style="text-decoration: underline; ">)(l) Fiscal Year-End</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company’s fiscal year end is the last Saturday in <i><em style="font: inherit;"> December </em></i>which could result in a <i><em style="font: inherit;">52</em></i> or <i><em style="font: inherit;">53</em></i> week year. Fiscal year <i><em style="font: inherit;">2023</em></i> consisted of <i><em style="font: inherit;">52</em></i> weeks and <i><em style="font: inherit;">2022</em></i> consisted of <i><em style="font: inherit;">53</em></i> weeks.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2861333	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2645442	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1493582	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1863512	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	537975	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	525872	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	4892890	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	5034826	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	310960	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	158925	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4581930	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4875901	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	164700	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165240	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	27540	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	357480	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	25480	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	332000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	172000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	332000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P26Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.597	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	86000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	35398	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	649201	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	760305	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	339936	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	25153	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1075137	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	820856	usd
CY2023Q4	cpsh	Inrease In Sales Returns For Parts Of Credit Issued InreaseInSalesReturnsForPartsOfCreditIssued	104126	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	48974	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8155	usd
CY2023Q4	cpsh	Long Term Debt Maturities Repayments Of Principal Interest LongTermDebtMaturitiesRepaymentsOfPrincipalInterest	2242	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	54887	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	5096	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	7954	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	81919	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	456	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	456	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	82375	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	1726	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	357507	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	577866	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	142203	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	176676	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	499710	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	754542	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	582085	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	756268	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	132632	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	209609	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	209092	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	865928	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1253956	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	84955	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	80628	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	5071	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	143081	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	179481	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	263421	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	205878	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2732	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2698	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1569726	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2069436	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2069436	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2823978	usd
CY2023	cpsh	Deferred Tax Assets Effect Of Deferred Tax Expense DeferredTaxAssetsEffectOfDeferredTaxExpense	-499710	usd
CY2022	cpsh	Deferred Tax Assets Effect Of Deferred Tax Expense DeferredTaxAssetsEffectOfDeferredTaxExpense	-754542	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1569726	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2069436	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	416663	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	578214	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	142562	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	177036	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	22860	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1018	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	582085	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	756268	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	232000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	94000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1370296	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2131400	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14495709
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14424381
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1370296	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2131400	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14495709
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14424381
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	133102
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	251265
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14628811
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14675646
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15

Files In Submission

Name	View Source	Status
0001437749-24-007808-index-headers.html	Edgar Link	pending
0001437749-24-007808-index.html	Edgar Link	pending
0001437749-24-007808.txt	Edgar Link	pending
0001437749-24-007808-xbrl.zip	Edgar Link	pending
cpsh-20231230.xsd	Edgar Link	pending
cpsh20231229_10k.htm	Edgar Link	pending
ex_638760.htm	Edgar Link	pending
ex_638762.htm	Edgar Link	pending
ex_638763.htm	Edgar Link	pending
ex_638764.htm	Edgar Link	pending
ex_638800.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
cpsh-20231230_def.xml	Edgar Link	unprocessable
cpsh-20231230_lab.xml	Edgar Link	unprocessable
cpsh-20231230_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cpsh20231229_10k_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpsh-20231230_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2024 Q1 Form 10-K Financial Statement

#000143774924007808 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2024 Q1 Form 10-K Financial Statement

#000143774924007808 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh